Lymphatic Diseases  >>  granisetron intravenous  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
granisetron intravenous / Generic mfg.
AMENO-2, NCT00415103: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors

Completed
4
196
Europe
Aprepitant, Palonosetron, Granisetron
PETHEMA Foundation, Merck Sharp & Dohme LLC
Leukemia, Lymphoma
09/09
09/09

Download Options